Military & Government
Standardized TBI Evidence for Defense and Veteran Programs
Objective biomarker screening for blast exposure, deployment readiness, and veteran care — delivered at policy-level scale with secure longitudinal data infrastructure.
Military & Government
Objective biomarker screening for blast exposure, deployment readiness, and veteran care — delivered at policy-level scale with secure longitudinal data infrastructure.
The Challenge
Blast-related TBI is frequently undetected by conventional imaging and underreported by service members. Without objective screening tools, injuries go undocumented — affecting readiness determinations, benefits claims, and long-term care planning.
400K+
Military TBI Cases Since 2000
82%
Classified as Mild (Often Missed)
30%+
Veterans Report Chronic Symptoms
Capabilities
Standardized biomarker assessment for personnel exposed to blast overpressure events. Objective determination of neurotrauma presence and severity.
Comprehensive biomarker panels for veterans with suspected TBI. Objective evidence to support disability claims, treatment planning, and benefits determinations.
Serial biomarker tracking for service members across deployments. Detect cumulative exposure effects and intervene before clinical deterioration.
Aggregate biomarker data across units, installations, and deployments — supporting epidemiological analysis and policy formation.
Deployment Infrastructure
Consistent triage and assessment protocols deployable across installations, units, and theater environments.
Longitudinal biomarker data managed under secure, compliant infrastructure with appropriate access controls.
Full evidentiary chain-of-custody from specimen collection through final reporting — meeting institutional documentation standards.
Platform designed for policy-level implementation — from individual screenings to installation-wide programs.
Use Cases
Baseline biomarker assessment before deployment with post-deployment comparison. Detect subclinical injury that conventional screening misses.
Rapid biomarker assessment following blast events. Objective triage data to support evacuation, rest, and return-to-duty decisions.
Objective biomarker evidence to support VA disability claims and benefits determinations — providing measurable data where medical records may be incomplete.
Standardized biomarker data supporting DoD and VA research initiatives on blast-related neurotrauma, cumulative exposure, and long-term outcomes.
We work with military commands, VA programs, and government agencies to deploy standardized biomarker screening at scale.
© 2026 New World Partners Healthcare. All rights reserved.